(Q44047912)

English

Safety and efficacy of STI-571 (imatinib mesylate) in patients with bcr/abl-positive chronic myelogenous leukemia (CML) after autologous peripheral blood stem cell transplantation (PBSCT).

scientific article published in July 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Safety and efficacy of STI-571 (imatinib mesylate) in patients with bcr/abl-positive chronic myelogenous leukemia (CML) after autologous peripheral blood stem cell transplantation (PBSCT). (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

1 reference

based on heuristic

inferred from title

Andreas Hochhaus

12

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

author name string

Fischer T

1

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Reifenrath C

2

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Hess GR

3

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Corsetti MT

4

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Kreil S

5

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Beck J

6

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Meinhardt P

7

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Beltrami G

8

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Schuch B

9

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Gschaidmeier H

10

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Hehlmann R

11

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Carella A

13

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Huber C

14

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

publication date

1 July 2002

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

1220-1228

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

https://scigraph.springernature.com/pub.10.1038/sj.leu.2402565

0 references

Chronic myeloid leukemia: current treatment options

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402565

7 January 2021

based on heuristic

inferred from DOI database lookup

Current trends in the management of chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402565

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402565

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous transplants for chronic myelogenous leukaemia: results from eight transplant groups

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402565

7 January 2021

based on heuristic

inferred from DOI database lookup

Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402565

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402565

7 January 2021

based on heuristic

inferred from DOI database lookup

Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402565

7 January 2021

based on heuristic

inferred from DOI database lookup

The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402565

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute leukaemia in bcr/abl transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402565

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402565

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402565

7 January 2021

based on heuristic

inferred from DOI database lookup

bcr-abl, the hallmark of chronic myeloid leukaemia in man, induces multiple haemopoietic neoplasms in mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402565

7 January 2021

based on heuristic

inferred from DOI database lookup

BCR-ABL as a target for novel therapeutic interventions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402565

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402565

7 January 2021

based on heuristic

inferred from DOI database lookup

Structural mechanism for STI-571 inhibition of abelson tyrosine kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402565

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402565

7 January 2021

based on heuristic

inferred from DOI database lookup

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402565

7 January 2021

based on heuristic

inferred from DOI database lookup

Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402565

7 January 2021

based on heuristic

inferred from DOI database lookup

Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402565

7 January 2021

based on heuristic

inferred from DOI database lookup

Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402565

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous transplantation of in vivo purged PBSC in CML: comparison of FISH, cytogenetics, and PCR detection of Philadelphia chromosome in leukapheresis products

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402565

7 January 2021

based on heuristic

inferred from DOI database lookup

Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402565

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome of peripheral blood stem cell mobilization in advanced phases of CML is dependent on the type of chemotherapy applied.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402565

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy-induced mobilization of karyotypically normal PBSC for autografting in CML

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402565

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2402565

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44047912&oldid=2105977629"